At issue is what is called the Orange Book, a document published by the Food and Drug Administration that lists patents relevant to brand-name pharmaceuticals. Under a law meant to encourage ...

The financial regulator in the US has warned the pharma industry that it may consider legal action against companies that improperly list patents in the FDA's 'Orange Book' in order to block ...

He said that the party was maintaining an "orange book" where the names of such officials were being recorded and the details would be revealed at an appropriate time. "They should not just follow ...